{"nctId":"NCT00702845","briefTitle":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","startDateStruct":{"date":"2006-12-28","type":"ACTUAL"},"conditions":["Infertility"],"count":397,"armGroups":[{"label":"corifollitropin alfa 100 Âµg","type":"EXPERIMENTAL","interventionNames":["Drug: corifollitropin alfa (Org 36286)","Drug: gonadatropin releasing hormone (GnRH) antagonist (ganirelix)","Drug: human chorion gonadatropin (hCG)","Biological: progesterone","Drug: placebo-recFSH (follitropin alfa)","Biological: open-label recFSH"]},{"label":"recFSH 150 IU","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: recFSH (follitropin beta)","Drug: gonadatropin releasing hormone (GnRH) antagonist (ganirelix)","Drug: human chorion gonadatropin (hCG)","Biological: progesterone","Drug: placebo-corifollitropin alfa","Biological: open-label recFSH"]}],"interventions":[{"name":"corifollitropin alfa (Org 36286)","otherNames":["Org 36286"]},{"name":"recFSH (follitropin beta)","otherNames":["recFSH (Puregon/Follistim AQ Cartridge)"]},{"name":"gonadatropin releasing hormone (GnRH) antagonist (ganirelix)","otherNames":[]},{"name":"human chorion gonadatropin (hCG)","otherNames":[]},{"name":"progesterone","otherNames":[]},{"name":"placebo-recFSH (follitropin alfa)","otherNames":[]},{"name":"placebo-corifollitropin alfa","otherNames":[]},{"name":"open-label recFSH","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Females of couples with an indication for COS and IVF or ICSI;\n* \\>=18 and \\<= 36 years of age at the time of signing informed consent;\n* Body weight \\<= 60 kg and BMI \\>= 18 and \\<= 32 kg/m\\^2;\n* Normal menstrual cycle length: 24-35 days;\n* Availability of ejaculatory sperm (use of donated and/or cryopreserved sperm is allowed);\n* Willing and able to sign informed consent.\n\nExclusion Criteria:\n\n* History of/or any current (treated) endocrine abnormality;\n* History of ovarian hyper-response or ovarian hyperstimulation syndrome\n\n(OHSS);\n\n* History of/or current polycystic ovary syndrome (PCOS);\n* More than 20 basal antral follicles \\<11 mm (both ovaries combined) as measured on USS in the early follicular phase (menstrual cycle day 2-5);\n* Less than 2 ovaries or any other ovarian abnormality (including endometrioma \\> 10 mm; visible on USS);\n* Presence of unilateral or bilateral hydrosalphinx (visible on USS);\n* Presence of any clinically relevant pathology affecting the uterine cavity or fibroids \\>= 5 cm;\n* More than three unsuccessful IVF cycles since the last established ongoing\n\npregnancy (if applicable);\n\n* History of non- or low ovarian response to FSH/hMG treatment;\n* History of recurrent miscarriage (3 or more, even when unexplained);\n* FSH \\> 12 IU/L or LH \\> 12 IU/L as measured by the local laboratory (sample taken during the early follicular phase: menstrual cycle day 2-5);\n* Any clinically relevant abnormal laboratory value based on a sample taken during the screening phase;\n* Contraindications for the use of gonadotropins (e.g. tumors, pregnancy/lactation, undiagnosed vaginal bleeding, hypersensitivity, ovarian cysts);\n* Recent history of/or current epilepsy, HIV infection, diabetes, cardiovascular,\n\ngastro-intestinal, hepatic, renal or pulmonary disease;\n\n* Abnormal karyotyping of the patient or her partner (if karyotyping is performed);\n* Smoking more than 5 cigarettes per day;\n* History or presence of alcohol or drug abuse within 12 months prior to signing informed consent;\n* Previous use of Org 36286;\n* Use of hormonal preparations within 1 month prior to randomization;\n* Hypersensitivity to any of the concomitant medication prescribed as part of the treatment regimen in this protocol;\n* Administration of investigational drugs within three months prior to signing informed consent.","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"36 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Cumulus-oocyte-complexes Retrieved, Per Attempt","description":"The primary efficacy parameter was defined as the number of cumulus-oocyte-complexes retrieved from participants in a controlled ovarian stimulation (COS) cycle for in vitro fertilization (IVF) and/or intracytoplasmic sperm injection (ICSI). For participants who did not have cumulus-oocyte-complex retrieval, the number retrieved was set to zero.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.3","spread":"7.3"},{"groupId":"OG001","value":"10.6","spread":"5.9"}]}]}]},{"type":"SECONDARY","title":"Total Dose of recFSH Administered","description":"Total dose of recFSH (IU) administered was defined as the total amount of recFSH needed by participants to reach the criterion for administration of hCG (at least 3 follicles \\>=17mm).","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"300.0","spread":null},{"groupId":"OG001","value":"1350.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Dose of recFSH Administered From Day 8 Onwards","description":"Total dose of recFSH (IU) needed from Stimulation Day 8 onwards to reach the criterion for administration of hCG (at least 3 follicles \\>=17mm).","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"300.0","spread":null},{"groupId":"OG001","value":"275.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Days Treated With recFSH","description":"Numbers of days treated with recFSH was defined as the total number of days participants received recFSH (excluding coasting days) until they reached the criterion for administration of hCG (at least 3 follicles \\>=17mm).","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":null},{"groupId":"OG001","value":"9.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Duration of Stimulation (Days)","description":"Total duration of stimulation was defined as the number of days from first drug administration up to and including the Day of hCG administration.","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.0","spread":null},{"groupId":"OG001","value":"9.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Serum Follicle Stimulating Hormone (FSH) Levels (Restricted to Participants With hCG Injection)","description":"Blood samples for assessment of serum FSH were taken prior to injection on Stimulation Day 1, Day 3, Day 5, Day 8, Day of hCG, Day of ET, at the visit two weeks after ET.","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.46","spread":"1.84"},{"groupId":"OG001","value":"6.51","spread":"1.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"26.30","spread":"7.14"},{"groupId":"OG001","value":"9.18","spread":"2.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.50","spread":"4.52"},{"groupId":"OG001","value":"10.20","spread":"2.98"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.10","spread":"2.12"},{"groupId":"OG001","value":"10.30","spread":"2.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.50","spread":"2.65"},{"groupId":"OG001","value":"10.65","spread":"3.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.52","spread":"1.05"},{"groupId":"OG001","value":"1.32","spread":"1.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.46","spread":"3.53"},{"groupId":"OG001","value":"1.90","spread":"NA"}]}]}]},{"type":"SECONDARY","title":"Serum Lutenizing Hormone (LH) Levels (Restricted to Participants With hCG Injection)","description":"Blood samples for assessment of serum LH were taken prior to injection on Stimulation Day 1, Day 3, Day 5, Day 8, Day of hCG, Day of ET, at the visit two weeks after ET.","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.46","spread":"1.81"},{"groupId":"OG001","value":"4.12","spread":"1.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.18","spread":"0.80"},{"groupId":"OG001","value":"1.46","spread":"1.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.91","spread":"3.70"},{"groupId":"OG001","value":"1.49","spread":"7.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":"NA"},{"groupId":"OG001","value":"1.60","spread":"2.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.88","spread":"NA"},{"groupId":"OG001","value":"1.30","spread":"2.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":"NA"},{"groupId":"OG001","value":"NA","spread":"NA"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.38","spread":"NA"},{"groupId":"OG001","value":"1.02","spread":"NA"}]}]}]},{"type":"SECONDARY","title":"Serum Estradiol (E2) Levels (Restricted to Participants With hCG Injection)","description":"Blood samples for assessment of serum E2 were taken prior to injection on Stimulation Day 1, Day 3, Day 5, Day 8, Day of hCG, Day of ET, at the visit two weeks after ET.","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"118.17","spread":"53.18"},{"groupId":"OG001","value":"120.38","spread":"71.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"803.73","spread":"553.18"},{"groupId":"OG001","value":"506.46","spread":"369.66"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1901.06","spread":"1490.48"},{"groupId":"OG001","value":"1295.51","spread":"1015.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2899.30","spread":"2632.83"},{"groupId":"OG001","value":"3167.21","spread":"2710.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4440.70","spread":"3355.95"},{"groupId":"OG001","value":"4440.70","spread":"3114.93"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3475.49","spread":"2640.49"},{"groupId":"OG001","value":"3670.00","spread":"2946.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"168.45","spread":"3002.09"},{"groupId":"OG001","value":"392.69","spread":"2889.61"}]}]}]},{"type":"SECONDARY","title":"Serum Progesterone (P) Levels (Restricted to Participants With hCG Injection)","description":"Blood samples for assessment of serum P were taken prior to injection on Stimulation Day 1, Day 3, Day 5, Day 8, Day of hCG, Day of ET, at the visit two weeks after ET.","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.36","spread":"2.90"},{"groupId":"OG001","value":"1.40","spread":"0.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.23","spread":"NA"},{"groupId":"OG001","value":"NA","spread":"NA"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.65","spread":"3.27"},{"groupId":"OG001","value":"1.28","spread":"NA"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.39","spread":"0.64"},{"groupId":"OG001","value":"2.03","spread":"1.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.10","spread":"1.34"},{"groupId":"OG001","value":"2.39","spread":"1.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"421.35","spread":"223.93"},{"groupId":"OG001","value":"333.90","spread":"157.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.64","spread":"263.88"},{"groupId":"OG001","value":"51.99","spread":"236.91"}]}]}]},{"type":"SECONDARY","title":"Serum Inhibin-B Levels (Restricted to Participants With hCG Injection)","description":"Blood samples for assessment of serum inhibin-B were taken prior to injection on Stimulation Day 1, Day 3, Day 5, Day 8, Day of hCG, Day of ET, at the visit two weeks after ET.","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54.20","spread":"26.40"},{"groupId":"OG001","value":"57.80","spread":"168.69"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"351.00","spread":"216.79"},{"groupId":"OG001","value":"259.00","spread":"143.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"598.00","spread":"527.96"},{"groupId":"OG001","value":"489.00","spread":"348.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"619.00","spread":"643.76"},{"groupId":"OG001","value":"650.00","spread":"536.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"729.50","spread":"721.20"},{"groupId":"OG001","value":"615.50","spread":"571.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.20","spread":"25.49"},{"groupId":"OG001","value":"17.00","spread":"29.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.50","spread":"NA"},{"groupId":"OG001","value":"NA","spread":"NA"}]}]}]},{"type":"SECONDARY","title":"Number and Size Distribution of Follicles During Stimulation and on the Day of hCG Administration","description":"For each participant, the number of follicles â¥11 mm, â¥15 mm, and â¥17 mm, documented by ultrasonography on defined days during the treatment cycle, was calculated.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.1"},{"groupId":"OG001","value":"0.0","spread":"0.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.1"},{"groupId":"OG001","value":"0.0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.1"},{"groupId":"OG001","value":"0.0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"1.7"},{"groupId":"OG001","value":"0.5","spread":"0.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.1"},{"groupId":"OG001","value":"0.0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.0"},{"groupId":"OG001","value":"0.0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.7","spread":"3.6"},{"groupId":"OG001","value":"4.1","spread":"3.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.3","spread":"0.7"},{"groupId":"OG001","value":"0.3","spread":"0.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.2"},{"groupId":"OG001","value":"0.0","spread":"0.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.6","spread":"5.2"},{"groupId":"OG001","value":"8.6","spread":"6.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"3.0"},{"groupId":"OG001","value":"4.0","spread":"3.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"1.3"},{"groupId":"OG001","value":"1.8","spread":"2.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.9","spread":"6.8"},{"groupId":"OG001","value":"9.2","spread":"4.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":"4.7"},{"groupId":"OG001","value":"3.3","spread":"2.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"2.8"},{"groupId":"OG001","value":"1.1","spread":"1.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.8","spread":"6.1"},{"groupId":"OG001","value":"10.6","spread":"5.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.0","spread":"4.6"},{"groupId":"OG001","value":"5.1","spread":"4.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":"3.0"},{"groupId":"OG001","value":"2.4","spread":"3.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.4","spread":"6.5"},{"groupId":"OG001","value":"11.1","spread":"5.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.9","spread":"4.7"},{"groupId":"OG001","value":"6.0","spread":"4.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":"2.5"},{"groupId":"OG001","value":"2.6","spread":"2.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.9","spread":"6.7"},{"groupId":"OG001","value":"13.0","spread":"6.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.4","spread":"4.9"},{"groupId":"OG001","value":"7.5","spread":"5.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.6","spread":"3.5"},{"groupId":"OG001","value":"4.0","spread":"4.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.9","spread":"6.7"},{"groupId":"OG001","value":"11.6","spread":"7.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.7","spread":"5.7"},{"groupId":"OG001","value":"7.1","spread":"4.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.9","spread":"3.8"},{"groupId":"OG001","value":"3.8","spread":"3.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.7","spread":"5.4"},{"groupId":"OG001","value":"9.3","spread":"4.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.8","spread":"3.5"},{"groupId":"OG001","value":"5.2","spread":"2.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":"2.8"},{"groupId":"OG001","value":"2.7","spread":"2.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.0","spread":"9.5"},{"groupId":"OG001","value":"10.3","spread":"5.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.6","spread":"8.6"},{"groupId":"OG001","value":"6.3","spread":"4.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.4","spread":"6.2"},{"groupId":"OG001","value":"4.0","spread":"3.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.5","spread":"12.0"},{"groupId":"OG001","value":"3.0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.5","spread":"12.0"},{"groupId":"OG001","value":"0.0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.0","spread":"5.7"},{"groupId":"OG001","value":"0.0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.0","spread":"0.0"},{"groupId":"OG001","value":"4.0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0","spread":"0.0"},{"groupId":"OG001","value":"4.0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":"0.0"},{"groupId":"OG001","value":"3.0","spread":"0.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.9","spread":"6.6"},{"groupId":"OG001","value":"12.9","spread":"5.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.4","spread":"4.9"},{"groupId":"OG001","value":"8.5","spread":"4.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.3","spread":"3.0"},{"groupId":"OG001","value":"5.1","spread":"3.0"}]}]}]},{"type":"SECONDARY","title":"Number and Quality of Oocytes Assessed Prior to ICSI (Restricted to Participants With ICSI Only)","description":"The number of oocytes used for ICSI was assessed and categorized based on their quality (i.e., metaphase I oocytes, metaphase II oocytes, and germinal vesicles stage oocytes).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.7","spread":"6.8"},{"groupId":"OG001","value":"9.9","spread":"5.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"1.2"},{"groupId":"OG001","value":"0.7","spread":"1.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.7","spread":"6.4"},{"groupId":"OG001","value":"7.8","spread":"4.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"1.6"},{"groupId":"OG001","value":"1.3","spread":"2.1"}]}]}]},{"type":"SECONDARY","title":"Fertilization Rate","description":"Fertilization rate, defined as 100 times the ratio of the number of fertilized 2 pronuclei (PN) oocytes obtained and the number of oocytes incubated, was tabulated for each treatment group.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67.6","spread":"22.5"},{"groupId":"OG001","value":"67.7","spread":"25.4"}]}]}]},{"type":"SECONDARY","title":"Number and Quality of Embryos Obtained at Day 3 (Restricted to Participants With IVF and/or ICSI)","description":"Embryo quality was rated Grade 1, 2, 3, or other. Grade 1 represented excellent quality; Grade 2 good quality; Grade 3 fair quality. \"Other\" grade embryos were those that did not qualify as Grade 1, 2, or 3.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.2","spread":"4.1"},{"groupId":"OG001","value":"6.2","spread":"4.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":"3.0"},{"groupId":"OG001","value":"3.0","spread":"3.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":"2.3"},{"groupId":"OG001","value":"1.4","spread":"2.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"1.9"},{"groupId":"OG001","value":"1.6","spread":"1.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":"2.8"},{"groupId":"OG001","value":"2.4","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"1.6"},{"groupId":"OG001","value":"0.7","spread":"1.7"}]}]}]},{"type":"SECONDARY","title":"Implantation Rate for Participants With ET","description":"The implantation rate was defined as 100 times the maximum number of gestational sacs as assessed by any ultrasound scan (USS) after ET divided by the number of embryos transferred (per participant), maximized to 100%.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23.6","spread":"37.4"},{"groupId":"OG001","value":"28.5","spread":"38.6"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Miscarriages","description":"A miscarriage, also known as a \"spontaneous abortion,\" was defined as the loss of a fetus without induction or instrumentation.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":"12.8"},{"groupId":"OG001","value":"4","spread":"8.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Pregnancies","description":"A Biochemical Pregnancy was defined as a pregnancy proven by a biochemical pregnancy test. (Participants not having a positive biochemical pregnancy test result, but with an ultrasound showing at least one gestational sac were counted as having a biochemical pregnancy.) A Clinical Pregnancy was defined as the presence of at least one gestational sac as assessed by an USS scan. A Vital Pregnancy was considered the presence of at least one fetus with heart activity as assessed by USS. An Ongoing Pregnancy was defined as the presence of at least one fetus with heart activity at least 10 weeks after ET as assessed by USS or Doppler, or confirmed by live birth.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"101","spread":null},{"groupId":"OG001","value":"58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"101","spread":null},{"groupId":"OG001","value":"58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"78","spread":null},{"groupId":"OG001","value":"48","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"78","spread":null},{"groupId":"OG001","value":"48","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69","spread":null},{"groupId":"OG001","value":"45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69","spread":null},{"groupId":"OG001","value":"45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"44","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":20,"n":268},"commonTop":["Pelvic discomfort","Pelvic pain","Headache","Antepartum haemorrhage","Abortion spontaneous"]}}}